SCHEMBL1665475

SCHEMBL1665475

Cc1nc2cc(-c3ccccc3)nn2c(O)c1C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
NPC1 O15118 9/20 0.61
RAB9A P51151 9/20 0.61
ALDH1A1 P00352 7/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
HPGD P15428 5/20 0.61
NFKB1 P19838 1/20 0.61
HTT P42858 1/20 0.61
NFKB2 Q00653 1/20 0.61
RELA Q04206 1/20 0.61
KDM4E B2RXH2 7/20 0.60
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
GAA P10253 2/20 0.54
LMNA P02545 2/20 0.47
TP53 P04637 2/20 0.47
HCRTR1 O43613 1/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2184555 0.86 KDM4E (0.55) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL13258606 0.85 NPC1 (0.67) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL5055343 0.85 MAPT (0.60) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL21775857 0.82 MAPT (0.57) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL21775472 0.82 MAPT (0.57) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL5052689 0.81 NPC1 (0.62) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL7067985 0.79 MAPT (0.74) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL29527482 0.79 NPC1 (0.58) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL8928795 0.78 MAPT (0.52) MAPTNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL19194883 0.78 KDM4E (0.46) MAPTALDH1A1SMN1; SMN2HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010086040-A1 PYRAZOLO-PYRIMIDINES FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA, LTD. (BS) 2010-08-05 WO claimed
EP-1891042-B1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA SA (BE) 2013-10-02 EP disclosed
EP-2308870-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed
EP-2308867-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed
WO-2010086040-A1 PYRAZOLO-PYRIMIDINES FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA, LTD. (BS) 2010-08-05 WO disclosed